Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nature Communications

• Publication date

  2012-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ncomms1892PMID 22673910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Understanding the language of Lys36 methylation at histone H3

  2012cited by this paper
• Hypoxic regulation of the cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway

  2012cited by this paper
• Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells.

  2011cited by this paper
• CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression.

  2011cited by this paper
• Histone H3 lysine 9 trimethylation and HP1γ favor inclusion of alternative exons

  2011cited by this paper
• A Perspective on Cancer Cell Metastasis

  2011cited by this paper
• Tumor entrained neutrophils inhibit seeding in the premetastatic lung.

  2011cited by this paper
• The biology of cancer metastasis.

  2011cited by this paper
• CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth.

  2011cited by this paper
• Genome-Wide Approaches Reveal Functional Interleukin-4-Inducible STAT6 Binding to the Vascular Cell Adhesion Molecule 1 Promoter

  2011cited by this paper
• An ESRP‐regulated splicing programme is abrogated during the epithelial–mesenchymal transition

  2010cited by this paper
• Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models

  2010cited by this paper
• CD44+ slow‐cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis

  2010cited by this paper
• Metastasis: cancer cell’s escape from oxidative stress

  2010cited by this paper
• DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability

  2010cited by this paper
• Association of reactive oxygen species levels and radioresistance in cancer stem cells

  2009cited by this paper
• Molecular basis of metastasis.

  2009cited by this paper
• The Integrated Genome Browser: free software for distribution and exploration of genome-scale datasets

  2009cited by this paper
• ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.

  2009cited by this paper
• High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability

  2009cited by this paper
• Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway

  2009cited by this paper
• CD44 Variant Isoforms Promote Metastasis Formation by a Tumor Cell-Matrix Cross-talk That Supports Adhesion and Apoptosis Resistance

  2009cited by this paper
• The x  c− cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases

  2008cited by this paper
• An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

  2008cited by this paper
• Molecular basis of metastasis.

  2008cited by this paper
• A chromatin landmark and transcription initiation at most promoters in human cells.

  2007cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Phenotypic characterization of human colorectal cancer stem cells

  2007cited by this paper
• Metastasis: a question of life or death

  2006cited by this paper
• Cancer metastasis: building a framework.

  2006cited by this paper
• Molecular markers of breast cancer metastasis

  2005cited by this paper
• Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

  2005cited by this paper
• Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance.

  2005cited by this paper
• Prospective identification of tumorigenic prostate cancer stem cells.

  2005cited by this paper
• Breast cancer metastasis: markers and models

  2005cited by this paper
• Redox Imbalance in Cystine/Glutamate Transporter-deficient Mice*

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

  2004cited by this paper
• Mechanism and biological significance of CD44 cleavage

  2004cited by this paper
• Cell–matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca2+ influx and PKC activation

  2004cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• CD44: From adhesion molecules to signalling regulators

  2003cited by this paper
• Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing

  2002cited by this paper
• CD44 is required for two consecutive steps in HGF/c-Met signaling.

  2002cited by this paper
• A question of life or death.

  2001cited by this paper
• CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes.

  2001cited by this paper
• Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc− cystine transporter: a new action for an old drug

  2001cited by this paper
• Nontransgenic models of breast cancer.

  2000cited by this paper
• Nontransgenic models of breast cancer

  2000cited by this paper
• Clinical studies of reversal of drug resistance based on glutathione.

  1998cited by this paper
• Induction of Apoptosis of Metastatic Mammary Carcinoma Cells In Vivo by Disruption of Tumor Cell Surface CD44 Function

  1997cited by this paper
• Building the Framework

  1996cited by this paper
• Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells.

  1995cited by this paper
• CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor

  1995cited by this paper
• The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat.

  1993cited by this paper
• A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

  1991cited by this paper
• Transport of cystine and cysteine and cell growth in cultured human diploid fibroblasts: Effect of glutamate and homocysteate

  1982cited by this paper
• Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

  1979cited by this paper
• Anal Bioanal Chem (2011) 400:1895–1904 DOI 10.1007/s00216-011-4895-5 ORIGINAL PAPER

  year unknowncited by this paper

• The identification of RNA splicing aberrations and their potential regulatory network in Chinese non-small cell lung cancer.

  2026cites this paper
• ESRP1 drives epithelial-mesenchymal transition by activating EPAC-RAP1A signaling axis.

  2026cites this paper
• RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs.

  2025cites this paper
• Rewiring amino acids in cancer.

  2025cites this paper
• Drug Repurposing Screen Identifies Pimozide as a ROS‐Inducing Therapy With Anti‐Tumor Efficacy in HNSCC PDX Models

  2025cites this paper
• Splicing diversity enhances the molecular classification of pituitary neuroendocrine tumors

  2025cites this paper
• Natural products targeting cancer stem cells: a promising therapeutic approach

  2025cites this paper
• The Alternative Splicing of CLSTN1 Driven by ESRP1 Suppresses Gastric Cancer Metastasis

  2025cites this paper
• Alternative Splicing in Tumorigenesis and Cancer Therapy

  2025cites this paper
• Nuclear RNA cap-chaperones eIF4E and NCBP2 govern distinct fates for 1000s of mRNAs uncovering an unexpected regulatory point in gene expression

  2025cites this paper
• Navigating a complex dance: the interplay between RNA-binding proteins and T cells in oral epithelial plasticity

  2025cites this paper
• MEN1 Promotes Ferroptosis by Disrupting CD44 Alternative Splicing to Suppress Lung Cancer

  2025cites this paper
• CD44: a key regulator of iron metabolism, redox balance, and therapeutic resistance in cancer stem cells

  2025cites this paper
• Alternative Splicing-Mediated Resistance to Antibody-Based Therapies: Mechanisms and Emerging Therapeutic Strategies

  2025cites this paper
• A superior method for antitumor therapy and application: dual-ligand nanomedicines.

  2025cites this paper
• FROM ISOFORMS TO INVASION - "HOW CD44/ESRP1 ISOFORM SWITCHING DRIVES METASTASIS AND CANCER STEMNESS.

  2025cites this paper
• New insights into Notch signaling as a crucial pathway of pancreatic cancer stem cell behavior by chrysin-polylactic acid-based nanocomposite

  2025cites this paper
• CD44v, S1PR1, HER3, MET and cancer‐associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb

  2025cites this paper
• Reprogramming of amino acid metabolism in breast cancer.

  2025cites this paper
• Transcriptomic analysis reveals lung cancer and subtype-specific alternative splicing biomarkers regulated by RNA-binding proteins

  2025cites this paper
• The highly metastatic 4T1 breast carcinoma model possesses features of a hybrid epithelial/mesenchymal phenotype

  2024cites this paper
• The role of SLC7A11 in diabetic wound healing: novel insights and new therapeutic strategies

  2024cites this paper
• Laser-responsive erastin-loaded chondroitin sulfate nanomedicine targeting CD44 and system xc- in liver cancer: A non-ferroptotic approach.

  2024cites this paper
• Molecular biological role of epithelial splicing regulatory protein 1 in intrahepatic cholangiocarcinoma

  2024cites this paper
• A Distinct Alternative mRNA Splicing Profile Identifies the Oncogenic CD44 Transcript Variant 3 in KMT2A-Rearranged Pediatric T-cell Acute Lymphoblastic Leukemia Cells

  2024cites this paper
• SPTBN2 suppresses ferroptosis in NSCLC cells by facilitating SLC7A11 membrane trafficking and localization

  2024cites this paper
• Calcium deposition in chicken eggshells: role of host genetics and gut microbiota

  2024cites this paper
• RBM10 loss induces aberrant splicing of cytoskeletal and extracellular matrix mRNAs and promotes metastatic fitness

  2024cites this paper
• MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells

  2024cites this paper
• Reciprocal Molecular Dialogues Between Ovarian Cancer Stem Cells and Their Microenvironmental Niches

  2024cites this paper
• Targeting the "tumor microenvironment": RNA-binding proteins in the spotlight in colorectal cancer therapy.

  2024cites this paper
• Nanodelivery Optimization of IDO1 Inhibitors in Tumor Immunotherapy: Challenges and Strategies

  2024cites this paper
• Biomineralization-Tuned Nanounits Reprogram the Signal Transducer and Activator of Transcription 3 Signaling for Ferroptosis-Immunotherapy in Cancer Stem Cells.

  2024cites this paper
• Dysregulation of ADAM10 shedding activity in naked mole‐rat fibroblasts is due to deficient phosphatidylserine externalization

  2023cites this paper
• Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling

  2023cites this paper
• RNA splicing dysregulation and the hallmarks of cancer

  2023cites this paper
• Comparative RNA-Seq Analysis Revealed Tissue-Specific Splicing Variations during the Generation of the PDX Model

  2023cites this paper
• Spontaneous metastasis xenograft models link CD44 isoform 4 to angiogenesis, hypoxia, EMT and mitochondria‐related pathways in colorectal cancer

  2023cites this paper
• ESRP1-driven alternative splicing of CLSTN1 inhibits the metastasis of gastric cancer

  2023cites this paper
• Characterization of Alternative Splicing in High-Risk Wilms’ Tumors

  2023cites this paper
• RNA-binding proteins regulating the CD44 alternative splicing

  2023cites this paper
• Proteolysis of CD44 at the cell surface controls a downstream protease network

  2023cites this paper
• Role of epithelial splicing regulatory protein 1 in cancer progression

  2023influential citation
• The v8-10 variant isoform of CD44 is selectively expressed in the normal human colonic stem cell niche and frequently is overexpressed in colon carcinomas during tumor development

  2023cites this paper
• Genomic Breakpoint Characterization and Transcriptome Analysis of Metastatic, Recurrent Desmoplastic Small Round Cell Tumor

  2023cites this paper
• Promotion of squamous cell carcinoma tumorigenesis by oncogene‐mediated THG‐1/TSC22D4 phosphorylation

  2023cites this paper
• Targeting lysine-specific demethylase 1 (KDM1A/LSD1) impairs colorectal cancer tumorigenesis by affecting cancer cells stemness, motility, and differentiation

  2023cites this paper
• Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models

  2023cites this paper
• Aurora kinase A regulates cancer-associated RNA aberrant splicing in breast cancer

  2023cites this paper
• The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis

  2023cites this paper
• Multi-omics analysis of the Indian ovarian cancer cohort revealed histotype-specific mutation and gene expression patterns

  2023cites this paper
• Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma

  2023cites this paper
• CD98 regulates the phosphorylation of HER2 and a bispecific anti‐HER2/CD98 antibody inhibits the growth signal of human breast cancer cells

  2023cites this paper
• The discovery, function, and regulation of epithelial splicing regulatory proteins (ESRP) 1 and 2.

  2023cites this paper
• Modulating tumor-stromal crosstalk via a redox-responsive nanomedicine for combination tumor therapy.

  2023cites this paper
• A Narrative Review on CD44’s Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence

  2023cites this paper
• CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance

  2023cites this paper
• Dysregulation of ADAM10 shedding activity in naked mole-rat fibroblasts is due to deficient phosphatidylserine externalisation

  2022cites this paper
• Alternative splicing downstream of EMT enhances phenotypic plasticity and malignant behavior in colon cancer

  2022influential citation
• ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer

  2022cites this paper
• Is depression the missing link between inflammatory mediators and cancer?

  2022cites this paper
• Cell adhesion molecule CD44v10 promotes stem-like properties in triple-negative breast cancer cells via glucose transporter GLUT1-mediated glycolysis

  2022cites this paper
• Integrating machine learning to construct aberrant alternative splicing event related classifiers to predict prognosis and immunotherapy response in patients with hepatocellular carcinoma

  2022cites this paper
• RNA Binding Proteins (RBPs) and their role in DNA Damage and radiation response in cancer.

  2022cites this paper
• A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses

  2022cites this paper
• Amino Acid Metabolism in Cancer Drug Resistance

  2022cites this paper
• The RNA-binding proteins CELF1 and ELAVL1 cooperatively control the alternative splicing of CD44.

  2022cites this paper
• The Role of Alternative Splicing in Cancer: Regulatory Mechanism, Therapeutic Strategy, and Bioinformatics Application

  2022cites this paper
• Noncoding RNAs: Regulating the crosstalk between tumor-associated macrophages and gastrointestinal cancer.

  2022cites this paper
• TDP43 promotes stemness of breast cancer stem cells through CD44 variant splicing isoforms

  2022cites this paper
• Establishment of a New Canine Inflammatory Mammary Carcinoma Cell Line and Analysis of its Cystine-glutamate Transporter Subunit Expression

  2022cites this paper
• Dysregulation of ADAM10 shedding activity as a mechanism of cancer resistance in the naked mole-rat

  2022cites this paper
• Myc pathway-guided alternative splicing events predict the overall survival of lung squamous cell carcinoma

  2022cites this paper
• CD44v3,8‐10 is essential for Slug‐dependent vimentin gene expression to acquire TGF‐β1‐induced tumor cell motility

  2022cites this paper
• Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer

  2022cites this paper
• Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis

  2022cites this paper
• PFKFB4 facilitates palbociclib resistance in oestrogen receptor‐positive breast cancer by enhancing stemness

  2022cites this paper
• The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer

  2022cites this paper
• Investigation of hemogram, oxidative stress, and some inflammatory marker levels in neonatal calves with escherichia coli and coronavirus diarrhea.

  2022cites this paper
• Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression

  2022cites this paper
• RBPMS2, as a novel biomarker for predicting lymph node metastasis, guides therapeutic regimens in gastric cancer

  2022cites this paper
• CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502–5p/KRAS and IGF2BP2/Myc axes

  2021cites this paper
• Overexpression of Epithelial Splicing Regulatory Protein 1 in Metastatic Lesions of Serous Ovarian Carcinoma Correlates with Poor Patient Prognosis

  2021cites this paper
• Methylation Modification, Alternative Splicing, and Noncoding RNA Play a Role in Cancer Metastasis through Epigenetic Regulation

  2021cites this paper
• Alternative RNA splicing in stem cells and cancer stem cells: Importance of transcript-based expression analysis

  2021cites this paper
• Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma

  2021cites this paper
• A fluorescent aptasensor based on copper nanoclusters for optical detection of CD44 exon v10, an important isoform in metastatic breast cancer.

  2021cites this paper
• Role of alternative splicing events in endometrial cancer prognosis.

  2021cites this paper
• Metastatic Breast Cancer, Organotropism and Therapeutics: A Review.

  2021cites this paper
• The RNA-Binding Protein ESRP1 Modulates the Expression of RAC1b in Colorectal Cancer Cells

  2021cites this paper
• Comprehensive Analysis of Alternative Splicing in Gastric Cancer Identifies Epithelial–Mesenchymal Transition Subtypes Associated with Survival

  2021cites this paper
• Sinomenine protects bone from destruction to ameliorate arthritis via activating p62Thr269/Ser272-Keap1-Nrf2 feedback loop.

  2021cites this paper
• Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition

  2021cites this paper
• Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target

  2021cites this paper
• Nanopore Sequencing Unveils Diverse Transcript Variants of the Epithelial Cell-Specific Transcription Factor Elf-3 in Human Malignancies

  2021cites this paper
• CD44 alternative splicing senses intragenic DNA methylation in tumors via direct and indirect mechanisms

  2021cites this paper
• Identification of prognostic and bone metastasis‐related alternative splicing signatures in mesothelioma

  2021cites this paper
• Identification of a Three-RNA Binding Proteins (RBPs) Signature Predicting Prognosis for Breast Cancer

  2021cites this paper
• Epithelial Splicing Regulatory Protein 1 Is Overexpressed in Breast Cancer and Predicts Poor Prognosis for Breast Cancer Patients

  2021cites this paper
• The Estrogen Receptor α Signaling Pathway Controls Alternative Splicing in the Absence of Ligands in Breast Cancer Cells

  2021cites this paper